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ABSTRACT 
The model of developmental origins of health and disease proposes that organisms 
during fetal period utilize cues that enable their adaptation in the postnatal environment 
they are likely to live, having short-term advantages when trying to survive in 
environment but simultaneously in the long run have costs for health.  A large body of 
epidemiological research has found that low birth weight, a marker of intrauterine 
conditions, is associated with cardiovascular (CV) disease. Since the reported 
associations of birth weight with normal variation in the resting blood pressure (BP), a 
major predictor of CV disease risk, have been modest, a key candidate mediating the 
link has been CV and hypothalamus-pituitary-adrenal –axes (HPAA) reactivity to stress. 
In addition, not only weight at birth but also gestational age and early postnatal growth 
may have independent associations to stress reactivity.  
The aim of this thesis was to investigate whether pre- and postnatal growth and 
gestational age are associated with CV and HPAA activity before, during and after 
stress in childhood and in late adulthood. Altogether 287 men and women aged 60-70 
and 299 boys and girls aged 7-9 underwent Trier Social Stress Test. Several indices of 
HPAA and CV were measured and birth size and gestational age were obtained from 
birth records.  
Results showed that low birth weight was associated with low HPAA activity during 
psychosocial stress, and rapid gain in BMI during years 7-11 was related to heightened 
stress reactivity to psychosocial stress. Size at birth in children and gestational age and 
early postnatal (0-2 years) gain in height in adults were associated with CV stress 
responses; however, in a sex-specific manner. Given that CV stress responses and 
HPAA activity are markers of CV disease vulnerability, our results may partly explain 
the associations between early environment and later CV disease. 
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TIIVISTELMÄ 
Elinkaarinäkökulman mukaan kohdun sisäinen kasvuympäristö muokkaa sikiön elinten 
rakennetta ja toimintaa niin, että yksilö valmistautuu kohtaamaan syntymän jälkeisen 
ympäristön haasteet. Nämä muutokset voivat olla lyhyellä tähtäimellä hyödyllisiä, mutta 
samalla aiheuttaa häiriöitä aikuisiän terveydentilassa. Pieni syntymäkoko, jota käytetään 
usein kuvaamaan kohdunsisäisiä olosuhteita, on epidemiologisissa tutkimuksissa 
havaittu olevan yhteydessä aikuisiän korkeampaan riskiin sairastua sydän- ja 
verisuonitauteihin. Koska syntymäkoon yhteys lepoverenpaineeseen on kuitenkin melko 
heikko, onkin ehdotettu että varhainen kasvuympäristö muokkaakin enemmän sekä 
kardiovaskulaarijärjestelmän että  hypothalamus-aivolisäke-lisämunuais –akselin 
(HPAA) stressireaktiivisuutta, joka voi myös altistaa yksilön sydän- ja 
verisuonitaudeille. 
Tämän tutkimuksen tarkoituksena oli selvittää eri ikäryhmiin kuuluvilla henkilöillä 
syntymäkoon, raskauden keston ja varhaislapsuuden painoindeksin ja pituuden 
muutosten yhteys yksilön fysiologiseen aktiivisuuteen ennen stressiä, stressin aikana ja 
stressin jälkeen. 287 aikuista iältään 60-70 vuotta ja 299 lasta iältään 6-8 vuotta kävivät 
läpi Trierin Sosiaalisen Stressikokeen (TSST). Henkilöiltä mitattiin useita eri 
kardiovaskulaarisia ja HPAA –suureita. 
Tulokset osoittivat, että 60-70 -vuotiailla miehillä ja naisilla matala syntymäpaino oli 
yhteydessä matalaan HPA -aktiivisuuteen ja nopea painoindeksin nousu vuosien 7 ja 11 
välillä korkeaan verenpainereaktiivisuuteen psykososiaalisen stressin aikana. Tulokset 
osoittivat myös, että syntymäkoko lapsilla ja sekä raskauden kesto että pituuden kasvu 
kahden ensimmäisen elinvuoden aikana aikuisilla olivat yhteydessä useisiin 
kardiovaskulaarisiin ja autonomisiin vasteisiin stressin aikana tai stressistä 
palauduttaessa, mutta näissä tuloksissa oli eroavaisuuksia sukupuolten välillä. Koska 
HPAA ja kardiovaskulaarinen aktivaatio stressin aikana ja stressin jälkeen ovat sydän- 
ja verisuonitaudin riskitekijöitä, tulokset voivat osittain selittää varhaisen 
kasvuympäristön vaikutusta riskiin sairastua sydän- ja verisuonitauteihin.  
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1 INTRODUCTION 
During the past two decades, a large body of epidemiological evidence around the world 
has shown that small size at birth is linked with cardiovascular (CV) diseases such as 
heart disease and stroke (Barker, Winter, Osmond, Margetts, & Simmonds, 1989; 
Barker, Osmond, Forsen, Kajantie, & Eriksson, 2005; R. Huxley et al., 2007; Lawlor, 
Ronalds, Clark, Smith, & Leon, 2005; Osmond, Kajantie, Forsen, Eriksson, & Barker, 
2007; Stein et al., 1996). However, the mechanisms behind these associations are 
unclear. The reported associations of size at birth with normal variation in resting blood 
pressure (BP) level have been inconsistent or surprisingly modest. (R. Huxley, Neil, & 
Collins, 2002; R. R. Huxley, Shiell, & Law, 2000; Kajantie, 2006; Law et al., 2002) and 
it has been suggested that rather than resting levels, the reactivity and recovery of both 
Hypothalamus Pituitary Adrenal –Axis (HPAA) and CV systems would link size at 
birth with CV diseases. It has also been recognized that developmental phases 
predisposing to adult CV outcomes include not only periods during fetal life but extend 
to infancy and childhood as well.  
1.1 Developmental Origins of Health and Disease (DOHaD) 
Many organisms during the fetal period are capable of developing in several ways by 
utilizing cues that enable their adaptation in the postnatal environment, in which they 
are likely to live. This “developmental plasticity” has probably evolved to facilitate 
survival and gain reproductive success. However, the problem is that the predictions 
may not be correct or the environment changes in time. Additionally, the developmental 
path that is selected may favour short-term survival, but still have damaging effects later 
in life. Being born small and having a slow metabolism might have short-term 
advantages when trying to survive in environments that are lacking in resources, but 
simultaneously in the long run have health disadvantages. Then again, being born large 
may benefit the individual development due to abundant resources early on, but 
simultaneously have adverse long-term consequences such as obesity, diabetes and 
cancer. (Gluckman, Hanson, Spencer, & Bateson, 2005)  
Besides increasing the probabilities of successful development, this early plasticity of 
the organism also suggests that disease processes may have early origins. From 
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epidemiological studies we have learned that both slow prenatal and slow postnatal 
growth increases the risk of later chronic disease (Barker et al., 1989; Barker, 1992; J. 
G. Eriksson et al., 2007; J. G. Eriksson, Forsen, Kajantie, Osmond, & Barker, 2007; 
Osmond et al., 2007)  and post-mortem studies have shown that there are signs of CV 
lesions already during early childhood (Berenson, Srinivasan, & Bao, 1997). The 
importance of early events in terms of disease development has since been confirmed 
both in experimental animal studies (Nuyt, 2008; Vieau et al., 2007) and in a number of 
different human populations (Jones et al., 2007; Raikkonen & Pesonen, 2009; Rich-
Edwards et al., 1997; Stein et al., 1996). In the medical field, the idea of investigating 
the health and disease effects of early physical growth has been designated 
“Developmental Origins of Health and Disease” (DOHaD). 
1.2 Programming of CV diseases  
In the field of DOHaD the concept of “programming” signifies a process whereby an 
adverse environmental stimulus, experienced in utero, induces long-term structural or 
functional effects on the developing organism. Several mechanisms that affect the 
disease process in the course of human development have been unravelled. However, 
some of the epidemiological findings are complex and still to be solved. One of the 
best-known is the mismatch of small size at birth showing much stronger relationships 
to several CV diseases including CHD (Rich-Edwards et al., 1997), stroke (Lawlor et 
al., 2005) and overt hypertension (J. Eriksson, Forsen, Tuomilehto, Osmond, & Barker, 
2000) than to their main risk-factors, resting BP level, which on average shows only 2 
mmHg increase in systolic BP (SBP) per one kg decrease in birth weight (R. R. Huxley 
et al., 2000).   
When investigating early origins of CV disease risk factors using size at birth and BP 
level as their equivalents, several issues need to be taken into consideration. First, size 
at birth is determined by summarized intrauterine growth rate and gestational age. Size 
at birth is often controlled for gestational age in order to concentrate on the effects of 
growth and the availability of resources during the prenatal environment rather than the 
time the fetus spends in the womb. In addition, gestational age might have health effects 
also independent of size at birth. Leon et al. (Leon, Johansson, & Rasmussen, 2000) 
showed in a sample of 165 000 men aged 17-19 that when both gestational age at birth 
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and birth weight were included in the model as predictors of systolic BP level, the 
statistically significant effect of gestational age was not affected, though statistical 
strength for birth weight was decreased. In a sample of 3100 women, gestational age 
even showed a stronger association with BP at the age of 31 than birth weight (Jarvelin 
et al., 2004). Gestational age has also been linked with cerebrovascular disease (Koupil, 
Leon, & Lithell, 2005) and stroke (Lawlor et al., 2005). Therefore, size at birth may be 
insufficient in capturing the early influences that give rise to paths to high BP and CV 
disease.  
Second, it has also been discovered that besides prenatal growth, growth during early 
postnatal life has major health effects. Especially slow growth during the prenatal 
period followed by rapid postnatal growth during infancy and childhood may be 
associated with heightened level of BP or a diagnosis of hypertension at an early age 
(Adair & Cole, 2003; Barker et al., 2005; Zhao et al., 2002). Then again, in an older 
cohort it was noticed that prenatal growth followed by a slow growth during infancy 
may also lead to an increased risk of developing CHD (Barker et al., 2005). Poor infant 
growth alone is also shown to predict coronary heart disease, and the effect has been 
stronger than for small size at birth (Fall, Vijayakumar, Barker, Osmond, & Duggleby, 
1995; Forsen, Eriksson, Osmond, & Barker, 2004). In order to clarify the role of 
postnatal growth within the disease process, epidemiological studies in the Helsinki 
Birth Cohort Study (HBCS) have with more careful analyses found several suboptimal 
childhood growth patterns associated with adult diagnosis of hypertension (J. Eriksson 
et al., 2000), coronary heart disease (Barker et al., 2005; J. G. Eriksson et al., 1999) and 
type 2 diabetes (J. G. Eriksson, Osmond, Kajantie, Forsen, & Barker, 2006).  
Third, associations of pre- and postnatal growth and gestational age with resting BP 
level are relatively modest compared to their associations with CV disease. It has 
therefore been suggested that the answer may not lie in pre- and postnatal predictors, 
but in the nature of the observed variable, i.e. the level of BP. Given that BP has great 
daily variations, and the highest strain to vessels occurs mostly when BP rises to its 
peak, investigations whether size at birth was linked to variation and pinnacles of BP 
started to appear. With a sample of 723 men, Koupil, Leon and Byberg (Koupil, Leon, 
& Byberg, 2005) showed that although weight at birth was not related to absolute level 
of BP, it was related to a relative increase in BP during working hours compared to the 
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usual daily level. Then again, in a sample of 104 men and 79 women aged 26 years, in 
women a one kg decrease in birth weight was associated with a 9 mmHg increase in 
SBP responses to cognitive stressors and a hypothetical confrontation scenario (Ward et 
al., 2004). In men, the association was not significant. In a sample of 721 men and 
women aged 58 years born at the time of the Dutch famine of 1944, in women a one kg 
decrease in birth weight was associated with a 5 mmHg increase in SBP response to 
psychosocial stress  (de Rooij et al., 2006; Painter et al., 2006). Again, the association 
was not significant in men. Furthermore, in studies with adult women born preterm 
(Kistner, Celsi, Vanpee, & Jacobson, 2000; Kistner, Celsi, Vanpee, & Jacobson, 2005; 
Pyhala et al., 2009) it was shown that gestational age, rather than birth weight, predicts 
adult systolic BP reactivity measured by 24-ambulatory BP recordings over 130 mmHg. 
Pyhälä et al. (Pyhala et al., 2009) also showed that very low birth weight individuals 
have heightened diastolic BP responses to psychosocial stress at the age of 23 when 
compared to matched controls born full-term. Given all these results, it is suggested that 
the pathway from size at birth and gestational age to adulthood CV disease might be 
connected through the higher reactivity of the CV system. 
Fourth, besides the activity of the CV system, the activity of HPAA has also been 
suggested as one of the key candidates in mediating the link between early growth and 
CV disease (Kajantie, 2006; Kajantie & Raikkonen, 2010; Seckl & Meaney, 2004). 
HPAA activity is related to precursors of CV disease, such as impaired glucose 
tolerance (Rosmond & Bjorntorp, 2000) and coronary calcification (K. Matthews, 
Schwartz, Cohen, & Seeman, 2006); however, the relationship between size at birth and 
postnatal HPAA activity is more complex. Size at birth has been associated both with 
hypocortisolism and hypercortisolism (Kajantie et al., 2002; Kajantie & Raikkonen, 
2010; Reynolds et al., 2005; Reynolds, 2010). Several of these studies have, however, 
assessed cortisol at a state of rest or after a biochemical activation of the axes. As with 
CV system, it has been suggested that rather than the resting level, HPAA reactivity to 
stress may be determined during the fetal period (Phillips & Jones, 2006). Indeed, this 
hypotheses has gained support from results from animal studies: early life 
manipulations have dissimilar effects on HPAA function at a resting stage and during 
stress (S. G. Matthews, 2002). In humans, a study consisting of young healthy male 
twins showed a negative association between birth weight and cortisol responses to 
15
psychosocial stress (Wust, Entringer, Federenko, Schlotz, & Hellhammer, 2005) and 
one other study consisting of singleton men and women found no association (de Rooij 
et al., 2006). However, in the latter study the response to stress was mild. Both the CV
system and HPAA activity during stress may offer key links mediating the relationship 
between early growth and CV disease. 
1.3 Prenatal growth, birth and early postnatal growth
Figure 1 depicts steps from conception to maturity by splitting growth into four additive 
and partly superimposed components, namely fetal period, infancy, childhood and 
puberty. The highest growth spurt can be witnessed during the fetal period, when 
growth velocity in relation to time makes an inverse u-shaped curve. There are also 
spurts of growth during early infancy and of puberty. 
Figure 1. Growth velocity throughout the human growth period (Kajantie 2003, with permission)
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Although the fetal genome signifies the prenatal (and postnatal) growth potential, the 
balance of evidence suggests that factors unrelated to the fetal genome determine 60-
75% of the resulting birth weight and 70-85% of gestational age (Clausson, 
Lichtenstein, & Cnattingius, 2000; Lunde, Melve, Gjessing, Skjaerven, & Irgens, 2007). 
Non-genomic factors that determine pre- and postnatal growth are mainly maternal 
nutrition, endocrine factors, sex, parity, maternal growth, smoking, medical 
complications, maternal social conditions, childhood social conditions, placental 
functioning and several other factors.  
Unlike pre- and postnatal growth, the regulation of the time of delivery in term 
pregnancies is not a well-known phenomenon. One of the key candidates is 
corticotropin-releasing hormone (CRH), which plays an important role in the etiology 
of preterm delivery associated with maternal or fetal stress (Lockwood, 1999) and also 
in parturition regulation in the case of primates (Bowman et al., 2001). In humans, a few 
studies suggest CRH as the likely determinant of the timing of human birth (McLean et 
al., 1995; Wadhwa, Porto, Garite, Chicz-DeMet, & Sandman, 1998) , but the exact 
pathways still remain unclear. CRH and most of the non-genomic growth factors, such 
as nutrition and hormones, participate in the development of the CV system and HPAA. 
Therefore, all these factors offer several potential mechanisms that may underlie the 
development of CV disease. 
1.4 Anatomy and maturation  
1.4.1 CV system  
The CV system is made up of the heart and the blood vessels, such as the veins and 
arteries, which by upholding BP move the blood around the body. BP is a product of 
cardiac output (CO) and peripheral resistance. The former is the amount of blood 
pumped by the heart during one minute and peripheral resistance a combination of 
elements that create resistance to regulate blood flow distribution in the periphery. 
Resistance in the periphery consists in a high degree of inherent constrictor tone in 
arterioles, which is called basal tone. Basal tone is mainly accounted for by an intrinsic 
property of vascular smooth muscle that is independent of neural or humoral influences 
and is caused by rhythmic contractions that are propagated from cell to cell. Basal tone 
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may be thought of as a (conceptual) reference point on which various vasomotor 
influences (neural and humoral) are expressed. Besides basal tone, peripheral resistance 
comprises a summation of vascular reactivity to several different contractile agonists. 
One of the most important regulators of the CV system is the autonomic nervous 
system (ANS). It is mainly efferent, transmitting signals from the central nervous 
system to peripheral organs. The ANS controls heart rate (HR) and the force of heart 
contraction, the constriction and dilatation of blood vessels, and the contraction and 
relaxation of smooth muscle in various organs. It is divided into two separate divisions, 
parasympathetic and sympathetic, based on both anatomical and functional differences.  
The ANS has the capability to cause rapid increases in arterial pressure. For this 
purpose, the entire vasoconstrictor and cardiac accelerating functions of the sympathetic 
nervous system (SNS) are stimulated as a unit. At the same time, there is a reciprocal 
de-activation of the parasympathetic vagal inhibitory signals to the heart. In 
consequence, arterioles, veins and other large vessels constrict and the heart itself is 
directly stimulated further enhancing cardiac pumping. With this short-term regulation 
of BP, vasomotor fibres from SNS, renal sympathetic nerves and circulating humoral 
agents play important roles in the regulation of organ blood flow. 
During the fetal period, all elements of the human ANS and peripheral nervous 
system are developed from the neural crest, which is an embryonic structure formed 
during the third and fourth week of fetal development. Neural crest cells migrate to 
several specific regions to form the basis of the sympathetic nervous system, and later 
on the parasympathetic nervous system. Morphological maturation of sympathetic 
ganglion cells emerges near twelve weeks of development, which then gives rise to the 
adrenal medulla, the principal site of the amino-acid tyrosine conversion to the 
catecholamines epinephrine and norepinephrine.  
Parasympathetic cholinergic nerves appear in human fetal atria from week 8 onwards 
and sympathetic-adrenergic nerves in the fetal heart in weeks 9 to 10 of development. 
However, it is suggested that the cardiac activity regulating parasympathetic and 
cholinergic tones emerges in weeks 15-17 and sympathetic tone even later during weeks 
23-28 (Papp, 1988).  After birth, sympathetic and parasympathetic innervations and 
cardiac regulatory systems continue to develop late into postnatal life (Robinson, 1996).  
18 
 
1.4.2 HPAA 
HPAA is an important neuroendocrine system, which involves parts of the 
hypothalamus, the anterior lobe of the pituitary gland and the adrenal cortices. Figure 2 
describes the functioning of the main parts of the axes in men and women. In general, 
hypothalamus releases corticotrophin-releasing hormone (CRH), which stimulates 
adrenocorticotropic hormone (ACTH). ACTH is then transported by the blood to the 
adrenal cortex of the adrenal gland, where it stimulates the biosynthesis of 
corticosteroids (such as cortisol) from cholesterol.  
HPAA maturation during the fetal period starts early on and fetal hypothalamus can 
be seen by 7 weeks of gestation and HPAA hormonal activity by eight to twelve weeks 
of gestation (Mesiano & Jaffe, 1997). Hypothalamic CRH can be identified by 16 weeks 
in the paraventricular nucleus and in other sites such as the hippocampus (Petraglia, 
Sutton, & Vale, 1989). CRH is the primary hypothalamic releasing factor regulating 
adrenocortical steroidogenesis and the growth of pituitary corticotrophs (a cell secreting 
ACTH) of the fetal HPAA (Rose et al. 1998), acting as a vasodilator of the fetoplacental 
circulation (Clifton et al., 1994) and also mediating the stress response. Although 
placental CRH is identical to hypothalamic CRH in structure and immunoreactivity, 
expression and secretion of placental CRH are increased and hypothalamic CRH 
decreased by glucocorticoids.  
 
 
Figure 2. The function of HPAA. 
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Another part of the HPAA is the adrenal cortex, which secretes an important 
homeostasis-maintaining hormone cortisol. Functional development of the adrenal 
cortex starts from four weeks of development and the precise onset of biosynthesis and 
production of cortisol has been only recently discovered. De novo cortisol production is 
available at 8 weeks of gestation (Goto et al., 2006), which influences the structural and 
functional development of a wide variety of fetal tissues, and is essential for the 
antepartum maturation of organ systems including the lungs, gastrointestinal tract, liver, 
and central nervous system. In addition, the largest part (appr. 80-90%) of the adrenal 
cortex consists of the “fetal zone” producing dehydroepiandrosterone (dhea), which 
serves as a precursor to male and female sex hormones and affects on the development 
of CV disease (Ebeling & Koivisto, 1994). 
Besides placental CRH, adrenocorticotropic hormone (ACTH) is one of the prime 
trophic hormones controlling and stimulating fetal adrenocortical growth and 
differentiation. It is produced in the anterior pituitary gland and acts via local mediators 
or growth factors in synchronizing fetal adrenocortical growth and angiogenesis. 
Hypothalamic CRH stimulates pituitary ACTH release by 14 to 20 weeks (Blumenfeld 
& Jaffe, 1986).  
 
1.5 Measuring CV and HPAA activity  
1.5.1 Measuring blood pressure  
In 1905, Korotkoff described the auscultatory sounds which became the foundation for 
the BP measurement techniques. It is still the most common method of BP measurement 
today. An air-filled cuff is wrapped around the patient's upper arm and it is inflated to 
occlude the brachial artery. As the cuff is allowed to deflate, a stethoscope is placed 
over the patient's brachial artery (distal to the cuff). The auscultatory technique is based 
on the ability of the human ear to detect and distinguish sounds. This is a great 
advantage since it allows the clinician to determine the quality of each measurement. 
However, inherent in this is the possibility for measurement error due to differences in 
hearing acuity from clinician to clinician. In an attempt to increase reproducibility, some 
automated devices have replaced the human ear with a microphone. 
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Unlike auscultatory techniques, which measure systolic and diastolic BP but estimate 
mean arterial pressure, oscillometric devices often measure the mean BP but estimate 
systolic and diastolic BP (Park, Menard, & Yuan, 2001). The term "oscillometric" refers 
to any measurement of the oscillations caused by the arterial pressure pulse. An air-
filled cuff is wrapped around the patient's arm or finger and the cuff is inflated to 
occlude the blood flow. As the cuff is allowed to deflate, pressure data is recorded by 
the device.  
During the early 1970’s, a method which relied on the principle of the "unloaded 
arterial wall" was introduced. Arterial pulsation was detected by a photoplethysmograph 
from a finger under a pressure cuff. The output of the plethysmograph is used to drive a 
“servo-loop”, which rapidly changes the cuff pressure to keep the output constant, so 
that the artery is held in a partially opened state. The oscillations of pressure in the cuff 
are then measured. By exploiting this method, the Finometer BP measurement device 
(used in studies I & III) gives an accurate and continuous estimate of the changes in 
systolic and diastolic BP, and also estimates cardiac output and peripheral resistance 
with the Modelflow method (Bogert & van Lieshout, 2005; Guelen et al., 2003).  
Another non-invasive BP measurement technique is called the tonometry, in which 
the radial artery is compressed against radial bone. Pulsations are then proportional to 
the intra-arterial pressure. The technique is based on an assumption that, under proper 
conditions, the artery wall does not influence the transmission of arterial pressure to a 
sensor applied to the skin. The technique is used for example in the Vasotrac BP 
measurement device applied in study IV. Vasotrac provides semi-continuous BP 
measurement and is well-validated against invasive arterial monitoring (Cua, Thomas, 
Zurakowski, & Laussen, 2005). 
1.5.2 Measuring sympathetic and parasympathetic nervous system 
activity 
Components of the autonomic nervous system (ANS), the SNS and parasympathetic 
nervous system (PNS), control cardiac and vascular activity. During recent decades, a 
few non-invasive measurement techniques have been developed to analyse both 
components separately. Especially the time-interval between ventricular depolarization 
to the beginning of left ventricular ejection, defined as pre-ejection period (PEP), is 
21 
 
used as an index of cardiac sympathetic activation due to its dependence of β-adrenergic 
inotropic drive to the left ventricle of the heart (Berntson et al., 1994). Then again, high 
frequency (0.12 – 0.40 Hz) fluctuations of heart rate (HF HRV) indicate vagal influence 
on the heart and work as an index of parasympathetic activity (Berntson et al., 1997). 
This index can be obtained by using a computational technique called Fast Fourier 
Transform (FFT) to the detrended and appropriately resampled time series of heart rate 
data. Besides CV markers, salivary alpha-amylase levels have also been found to 
correlate with norepinephrine levels and may be used as a proxy for SNS activity 
(Raikkonen et al., 2010; Rohleder, Nater, Wolf, Ehlert, & Kirschbaum, 2004). These 
markers are widely used and offer simple and indirect indices of ANS activity.  
1.5.3 Measuring HPAA activity 
Markers of HPAA activity, ACTH and cortisol concentrations, are often measured 
directly from blood. Cortisol may also be assessed from saliva or urine. However, 
cortisol in the blood stream is bound to circulating proteins, whereas in saliva-bound 
hormone components are too large to pass through when blood filters through the 
salivary glands. Therefore, salivary cortisol measurement is a reliable indicator of 
biologically active cortisol or “free” cortisol (Hellhammer, Wust, & Kudielka, 2009), 
whereas cortisol derived from blood indicates total cortisol, both bound and free.  
1.6 Stress  
Stress is an ambiguous concept that is used in different occasions to denote positive or 
negative strain in a physical or psychological context. Stress responses are adaptive and 
enable us to both survive and to recover from life-threatening physical demands. In 
1936, endocrinologist Hans Selye defined stress as the nonspecific response of the body 
to any demand (Selye, 1936). This nonspecificity meant that exposure to any stressor 
elicit same type of pituitary adrenocortical and sympathoadrenomedullary response. 
Although popular, this concept has since subsequently been refined and it has been 
found that different types of stressors have their own unique central neurochemical and 
peripheral pattern of responses (Pacak et al., 1998).  
Activation of the stress system leads to behavioral and peripheral changes that 
improve the ability of the organism to adjust to environmental demands and increase 
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its chances for survival. This concept of maintaining bodily homeostasis has been 
termed “allostasis”. When stress is chronic or physiological responses to stress are 
exaggerated or the stress system does not perform normally, various 
pathophysiological states may arise (Chrousos & Gold, 1992) and lead to allostatic 
load on the price of adaptation (McEwen & Gianaros, 2010).  
In the modern society, many of the demands one faces that are mental lead to 
increased physical stress reactivity compared to bodily needs. A wide body of 
evidence from a diversity of disciplines has shown that especially the psychosocial 
factors and modern-day psychological stress (Dimsdale, 2008) are related to mortality 
and morbidity due to CV diseases (Everson-Rose & Lewis, 2005). Psychosocial 
factors that relate to mortality and morbidity are mainly chronic and acute 
psychosocial stressors, social ties, social support, social conflict and negative 
emotional states (Everson-Rose & Lewis, 2005).   
1.6.1 Measuring psychological stress in the laboratory environment  
Individual differences in psychological stress reactivity are often measured by 
examining changes in physiological functioning elicited by aversive, challenging, or 
engaging laboratory tasks, such as mental arithmetic, cold pressor, or public speaking 
tasks. Given that each of these has their own unique pattern of responses, we can define 
our challenge by the strain to which we are interested in.  
During psychosocial stress, the human body maintains homeostasis by regulating 
CV, autonomic, endocrine, neurophysiological, metabolic and immunological activity, 
all of which interact and covary depending on the context. Moreover, both 
hyperreactivity and hyporeactivity of these systems may lead to the development of 
several CV disease states. The present studies have focused on responses of the CV 
system and HPAA to psychosocial stress.  
In order to achieve the highest ecological validity when studying stress in the 
laboratory environment, it is common to use different types of psychosocial stress tasks. 
Psychosocial stress tests, especially public speaking tasks, give a reliable and robust 
responses and activate both CV system and HPAA (Burleson et al., 2003; Dickerson & 
Kemeny, 2004). Furthermore, under psychosocial stress, BP is mainly driven by 
increased vascular resistance but also increased cardiac output. Higher cardiac output 
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during psychosocial stress is less evident in children (Jones et al., 2008), but in older 
individuals it is suggested to result from increased myocardial contractility (Uchino, 
Uno, Holt-Lunstad, & Flinders, 1999). Furthermore, evaluative observation results in 
increased beta-adrenergic activity (Kelsey et al., 2000), increased cortisol production  
(Dickerson & Kemeny, 2004) and robust vascular and myocardial responses (Christian 
& Stoney, 2006; Schommer, Hellhammer, & Kirschbaum, 2003). A meta-analysis of 
over 200 stress studies (Dickerson & Kemeny, 2004) suggested that by including social 
evaluative threat, unpredictability and by using a combination of speech tasks and 
cognitive tasks with a presence of evaluative observation, the most robust HPAA stress 
response is achieved. Therefore, the present studies applied Trier Social Stress Test 
(TSST), which is designed as a combination of each of these factors and offers a 
comprehensive activation of various physiological stress systems.  
1.6.2 Physiological hypo- or hyperreactivity of CV system and HPAA to 
stress  
Although the responses of both the CV and HPAA axes react to and are important 
during stressful situations, both the hypo- and hyperreactivity of these systems have 
major health outcomes, especially when they are considered chronic. Heightened BP 
reactivity to stress predicts the future resting level of BP (Carroll, Ring, Hunt, Ford, & 
Macintyre, 2003), and it has been linked with adult hypertension (K. A. Matthews et al., 
2004), increased left ventricular mass (Treiber et al., 2003) carotid atherosclerosis 
(Jennings et al., 2004) and all-cause mortality (Strandberg & Salomaa, 2000). Then 
again, chronic hypersecretion of cortisol is linked with central obesity, systemic arterial 
hypertension and impaired glucose tolerance (Arnaldi et al., 2003) and hypoactive 
HPAA has been associated with fibromyalgia (Wingenfeld et al., 2008) and chronic 
fatigue syndrome (Roberts, Wessely, Chalder, Papadopoulos, & Cleare, 2004). It has 
been suggested that this hypoactivity is a bodily defence mechanism after a long period 
of hyperactivity (Fries, Hesse, Hellhammer, & Hellhammer, 2005).  
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1.6.3 Physiological recovery from stress 
In addition to the magnitude of the rise during stress, prolonged elevation of CV activity 
after the end of the stressor has also been found to be an independent predictor of future 
BP level (Steptoe & Marmot, 2005), and the onset of hypertension (Singh, Petrides, 
Gold, Chrousos, & Deuster, 1999). In addition, prenatally malnourished (6% casein 
diet) rats have elevations in BP that persist for 15 minutes after an olfactory stressor had 
ended.(Tonkiss, Trzcinska, Galler, Ruiz-Opazo, & Herrera, 1998) Although mounting 
human evidence suggests that reduced growth during prenatal life is associated with the 
biology of stress response in adulthood, we do not know whether this phenomenon is 
reflected by a slow post-stress recovery of BP. 
1.7 Effects of sex and age  
Several studies that have investigated the programming of CV stress system have 
reported sex-specific results. Two studies found that low birth weight was associated 
with increased BP stress reactivity only in women (Jones et al., 2007; Ward et al., 2004) 
and one study found opposite associations between the sexes (Painter et al., 2006). The 
reasons behind the sex-specificity have remained unclear. Then again, the programming 
of HPAA activity has not had support for sex-specificity (Reynolds et al., 2005). 
However, there are only few human studies investigating the programming of HPAA 
reactivity and responses to stress. One study found an inverse association between birth 
weight and salivary cortisol response to stress only in 7-9 year old boys, but not in girls 
(Jones et al., 2008) and one study found no associations in either men or women (de 
Rooij et al., 2006). In the latter study, however, the HPAA stress response was mild.  
Both sex and age have several effects on both CV and HPAA dynamics during 
acute stress. Increasing age is accompanied by increased BP responses to stress 
especially in women (Kajantie & Phillips, 2006), and parasympathetic withdrawal 
(Uchino, Holt-Lunstad, Bloor, & Campo, 2005) as well as increases in plasma 
norepinephrine spillover (Esler et al., 1995) in both women and men. Elderly 
individuals also have reduced sympathetic influence on BP possibly due to reduction 
in vasomotor sympathetic responsiveness (Barnett et al., 1999). There are sex 
differences also in several mechanisms that underlie BP regulation and HPAA activity 
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(Convertino, 1998; Kajantie & Phillips, 2006; Reckelhoff, 2001). HPAA responses to 
psychosocial stress after puberty and before menopause are lower in women compared 
to men (Kajantie & Phillips, 2006) and it has been hypothesized that the sex 
differences to stress responses might be due to the evolutionary effect protecting the 
fetus from maternal stress responses (Kajantie & Phillips, 2006). Therefore, it is 
important to conduct several of the analyses in different age groups and separately for 
both sex, especially in studies of CV programming.  
1.8 Animal studies in DOHaD 
Underlying causal pathways in the field of DOHaD have mainly been referred from 
animal studies due to the possibility of manipulating various variables.  Experiments 
with rats, which had prenatal malnutrition by 6% casein diet during pregnancy, were 
found to have a higher diastolic BP response to olfactory stress (Tonkiss et al., 1998), 
reduced beta1-adrenergic receptor expression in the heart (Fernandez-Twinn, 
Ekizoglou, Wayman, Petry, & Ozanne, 2006) and increased predisposition to cardiac 
arrhythmias (Hu et al., 2000) in later life. In addition, low birth weight in female rats is 
associated with high plasma epinephrine level activity at the age of 3-4 months (Jansson 
& Lambert, 1999) and restrictions in both prenatal and postnatal growth result in 
increased BP and reduced nephron number in male rat offspring (Wlodek, Westcott, 
Siebel, Owens, & Moritz, 2008). One study also showed that rats with intra-uterine 
growth restriction do not have higher BP reactions to sound stress than control rats, but 
they do have a higher overall BP level (Schreuder, Fodor, van Wijk, & Delemarre-van 
de Waal, 2006).  
Then again, prenatal stress may lead to impaired prenatal growth and the subsequent 
exposure to excess glucocorticoids during critical windows of neuroendocrine 
development have several long-term health effects (Glover, O'Connor, & O'Donnell, 
2010; S. G. Matthews, 2002). Administration of exogenous corticosteroids to pregnant 
rats decreases the birth weight and raises the BP of their offspring in later life 
(Benediktsson, Lindsay, Noble, Seckl, & Edwards, 1993). Prenatal stress near term is 
associated with elevated plasma cortisol responses to acute stress (30 minute exposure 
to strobe light) (Kapoor, Dunn, Kostaki, Andrews, & Matthews, 2006). There is also 
good evidence that prenatal glucocorticoid exposure alters not only the development of 
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the HPAA but also sympathetic innervations (Bian, Seidler, & Slotkin, 1993), cardiac 
noradrenergic and sympathetic processes (Seckl & Meaney, 2004), and induces long-
term effects for ACTH, corticosteroid-binding globulin, BP and BP variability 
(Igosheva, Klimova, Anishchenko, & Glover, 2004; McCormick, Smythe, Sharma, & 
Meaney, 1995; Weinstock, Poltyrev, Schorer-Apelbaum, Men, & McCarty, 1998). 
Therefore, prenatal stress may underlie prenatal growth restrictions and lead to altered 
cardiac and HPAA activity in later life.  
In sum, animal models offer insight and suggest hypotheses for human programming 
of physiological activity during stress and also to its underlying mechanisms. We 
decided to investigate whether pre- and postnatal growth is associated with CV and 
HPAA activity before, during and after stress in childhood and late adulthood in both 
men and women. 
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2  AIMS OF THE STUDY 
1. To study whether prenatal growth and length of gestation are associated with 
CV reactivity to and recovery from psychosocial stress in childhood and in 
late adulthood (Studies I & IV) 
2. To examine whether prenatal growth and length of gestation are associated 
with HPAA reactivity to psychosocial stress in late adulthood (Study II) 
3. To study whether childhood growth is associated with CV reactivity to 
psychosocial stress in late adulthood (Study III) 
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3  METHODS 
3.1 Study populations 
Participants in the present studies came from two cohorts. Figure 3 depicts a flowchart 
for both cohorts. The participants in Studies I, II and III came from the Helsinki Birth 
Cohort Study, which consists of men (n=4630) and women (n=4130) who were born at 
Helsinki University Central Hospital during 1934–1944, attended child welfare clinics 
in the city of Helsinki, and were still resident in Finland in 1971, when personal 
identification numbers were allocated to all residents of the country. During the years 
2001–2004, at the average age of 61.5 years (SD = 2.9, range = 56.7–69.8), a subset of 
2003 women (n=1075) and men (n=928) participated in a clinical examination. They 
were selected from the initial study population using random number tables as described 
elsewhere (Barker et al., 2005). From those who had attended the clinical examination 
and who had appropriate early life data including length of gestation and measurement 
of body size at birth available, 287 women and men participated in an experimental 
stress protocol between 2004 and 2005. CV measurements were obtained from 153 
persons. Because of our focus on the life span consequences of slow intrauterine 
growth, we overrepresented by 33% participants whose birth weight adjusted for 
gestational age was below the 10th percentile of the entire birth cohort. The subjects 
were invited in random order.  
Data on the newborn’s date of birth, weight (g), length (cm), head circumference 
(cm), and the date of the mother’s last menstrual period, as well as childhood social 
class (lower, 79.1%, lower middle, 16.3%, upper 4.6%) based on the father’s 
occupation, were extracted from birth records. Ponderal index (PI) was calculated as 
(birthweight)/(birthlength)3.  
Participants in study IV came from the GLAKU cohort. They were recruited from a 
secondary birth hospital used by residents of a specific geographical area, with the 
exception of deliveries requiring tertiary level care. This cohort comprised initially 1049 
mothers and their infants born between March and November 1998 in Helsinki, Finland. 
In 2006, children and their parents were invited to participate in a follow-up with a 
focus on individual differences in psychophysiological development. 912 (86.9%) 
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mothers of the initial cohort agreed to be included in the follow-up and 890 (84.8% of 
the initial cohort) were traced. Because one of the original study objectives, which was 
however not focused on in this thesis, was to examine developmental consequences of 
maternal licorice consumption during pregnancy, the sample was weighed according to 
the mother’s licorice intake during pregnancy (Raikkonen et al., 2010; Strandberg, 
Jarvenpaa, Vanhanen, & McKeigue, 2001), as follows. 
We invited all 88 children belonging to the group whose mothers consumed high 
levels of licorice during pregnancy and 64 participated. The other invited children had 
to live within a 35-mile radius of Helsinki to manage costs relating to participant and 
researcher travel and accommodation. We invited 271 children whose mothers had 
consumed zero or low amounts of licorice and 54 children whose mothers consumed 
moderate levels of licorice. 211 and 46 participated, respectively. Of the 321 children 
who agreed to participate in the follow-up, 299 participated in the stress study (72.4%). 
We obtained weight (kg) and length (cm) at birth, date of birth and gestational age 
confirmed by ultrasound before 20 weeks of gestation, from birth records. The ponderal 
index was determined as the ratio of weight (kg) to the cube of length at birth (cm3). To 
better describe intrauterine growth, birth weight and birth length were transformed into 
z-scores (birth weight and birth length SD scores) for gestational age and sex based on 
Finnish standards (Pihkala, Hakala, Voutilainen, & Raivio, 1989). The socioeconomic 
status of the family was classified according to the self-reported occupation of the 
mothers in 2006 (lower, 8%; middle, 32.4%; upper, 59.5%). 
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Figure 3. Recruitment flowchart
3.2 Protocols
3.2.1 Trier Social Stress Test for Adults
In the first three studies we used TSST as a stress test. The training for TSST was done 
under the supervision of Professor Hellhammer in the Department of Psychobiology at 
the University of Trier, where the protocol has been developed. 
At the start of the TSST, the subject was asked to convince in five minutes a 
committee of two persons (Figure 4. - one man and one woman, who are dressed in 
white medical jackets) that he/she is the best candidate for a self-selected confidential 
post. To maximize ego involvement, the subject was specifically asked to focus on 
his/her personal abilities and not on any objectively measurable quantities such as work 
experience. The assistant showed the subject a video camera and tape recorder and told 
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analysis of their behaviour and success in the task. The subject was told to prepare the 
speech for 3 min. The subject stood in front of the seated committee who were 
instructed to minimize all verbal and non-verbal communication during the preparation 
period and the speech task. A mental arithmetic task followed immediately after the 
speech task. The subject remained standing and was asked to perform serial 
subtractions, starting from 509 and subtracting seven. The subtractions were asked to be 
performed as quickly as possible. If a mistake occurred, the committee notified the 
subject by saying ‘error’ and asked him/her to start again from 509. Although the 
arithmetic task and speech task both lasted for 5 min, the durations of the tasks were not 
revealed to the subject in advance. After the completion of both tasks, all monitoring 
devices were removed and the subject was led to another room for the recovery period. 
As TSST is a very powerful stressor, all the subjects underwent a brief debriefing 
session after the task with a trained psychology student, who was also a committee 
member.  
Figure 4. Trier Social Stress Test for Adults. The committee.
Before the experiment, the subject filled in all the questionnaires, rested for a total of 
45 min and was led to the laboratory. The subject remained standing throughout the 
baseline and the experimental stress protocol and the time in between them.  
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The study protocol was approved by the Ethical Committee of Epidemiology and 
Public Health Research at the Helsinki University Central Hospital. Written informed 
consent was obtained from each participant. 
3.2.3 Trier Social Stress Test for Children 
In the last study we applied Trier Social Stress for Children (TSST-C). Training was 
carried out by Dr Alex Jones from Southampton University, who had developed the 
protocol to suit the purposes of CV measurement (Buske-Kirschbaum et al., 1997; Jones 
et al., 2008). Prior to the st ress experiment, the subject completed a five-minute 
baseline recording in a standing position watching a relaxing movie next to a parent. 
The child was brought to another room without his/her parent and was introduced to a 
committee of two ‘judges’ (Figure 5). A selection of toys was presented and the child 
was asked to pick up the favourite and second favourite toy, and the favourite toy was to 
be a reward if the tasks were performed extremely well (at the end each child received 
this toy). These toys were placed and visible on a table between the child and the 
committee. The beginning of a story was played, and the child was asked to complete it 
in front of the committee and a tape recorder. The child was taken back to the baseline 
room, where the story was prepared with support and encouragement from a research 
nurse. Following this, the child was again taken in front of the committee to present the 
five-minute story, which was followed by a five-minute mental arithmetic task. After 
completion of the task, the child was given his/her favourite toy for an excellent 
performance, and was led to another peaceful room to continue watching the comforting 
movie started during baseline. After 13 minutes of watching the film, the child was 
asked to stand up. During a total of 12 minutes of standing, the last 5 minutes was 
determined as the post-stress recovery period. 
The Ethical Committee of the City of Helsinki Health Department and the Ethical 
Committee of Children’s and Adolescents’ Diseases and Psychiatry at Helsinki and the 
Uusimaa Hospital District had approved the protocol. 
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Figure 5. Trier Social Stress Test for Children
3.3 Physiological measures
In Studies I and III, a continuous beat-to-beat monitoring of BP and HR during the 
baseline and the task was conducted by Finometer (FMS, Amsterdam, The 
Netherlands), non-invasive finger photoplethysmograph. On average, systolic BP (SBP) 
and diastolic BP (DBP) measured by Finometer differ 2 mmHg from those measured by
a mercury sphygmomanometer, whereas the Association for the Advancement of 
Medical Instrumentation criteria for the reliability of BP measurements require a bias of 
5 mmHg and a variability of 8 mmHg against a mercury sphygmomanometer (Schutte, 
Huisman, van Rooyen, Malan, & Schutte, 2004). Finometer also estimates systemic 
haemodynamic function by the Modelflow method (Sugawara et al., 2003), which 
computes an aortic flow waveform by simulating a non-linear three-element model of 
the aortic input impedance. This provides an estimate of left ventricular stroke volume, 
cardiac output (CO; calculated as stroke volume * instantaneous HR and expressed as 
l/min) and total peripheral resistance (TPR; calculated as (mean arterial pressure/ CO) * 
80 and expressed as dynes s cm5). Rather than absolute values, in particular, relative 
changes in BP and stroke volume levels within an individual over time are most reliably 
measured by the Finometer device (Schutte, Huisman, Van Rooyen, Oosthuizen, &
Jerling, 2003). 
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In Study II, we measured the activity of HPAA. Salivary cortisol concentrations were 
determined using a competitive solid-phase, time-resolved fluorescence immunoassay 
with fluorometric end point detection (DELFIA; Wallac, Turku, Finland). Plasma 
cortisol concentrations were determined by ELISA (ImmunoBiological Laboratories, 
Hamburg, Germany) and ACTH by chemiluminescence immunofluorometric assay 
(Nichols Institute Diagnostics, San Clemente, CA).  
In Study IV, BP was monitored using Vasotrac APM205A (MedWave Inc, St. Paul, 
MN, USA) tonometer. Vasotrac performs well within Association of the Advancement 
of Medical Instrumentation (AAMI) criteria, when validated against intra-arterial 
measurement in a pediatric sample (Cua et al., 2005), and it allows semi-continuous 
(every 12-15 heartbeats) BP measurements by applying pressure to the radial artery of 
the non-dominant hand. CO, PEP and HR were measured with impedance cardiography 
(NICO100C; Santa Barbara, CA) and ECG (ECG100C; Santa Barbara, CA) using 
methodological guidelines by Sherwood et al. (Sherwood et al., 1990). All PEP values 
were corrected for respective heart rate value. High-frequency heart rate variability (HF 
HRV) was determined according to current guidelines (Berntson et al., 1994). Total 
peripheral resistance (TPR) was calculated as (mean arterial pressure/CO) * 80 and 
expressed as dynes * s * cm5. With this pattern of autonomic parameters we were able 
to investigate underlying vascular (TPR) and cardiac (CO) mechanisms for BP, and also 
autonomic activity (PEP&HF HRV), which relate to both BP and HR.  
All signals were subsequently fed with electrode leads into a Biopac MP150 system 
(Santa Barbara, CA) using a general purpose amplifier module (DA100). Signals were 
digitally sampled at 1000 Hz, and calibrated according to the manufacturer’s 
instructions. Data recording was performed with Biopac AcqKnowledge 3.8.1 software 
(Santa Barbara, CA) and data reduction with WinCPRS® 1.160 software (Absolute 
Aliens, Turku, Finland). 
3.4 Statistical analyses 
Because mental stress measures for CV activity are more reproducible when responses 
to individual tasks are aggregated (Kamarck & Lovallo, 2003), we averaged all CV 
readings in studies I and III from 5-minute baseline, 10-minute task (speech and 
arithmetic) and 5-minute post-stress period. Besides these activity levels, we calculated 
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increments from the averaged baseline value to task and in Study IV to the post-stress 
period to obtain reactivity to and recovery from stress for BP, HR, PEP and HRV HF 
values. These values were then used as dependent variables to be predicted by prenatal 
indices such as size at birth and gestational age.  
In Study II, cortisol and ACTH concentrations were log transformed to attain 
normality. We first analysed the responses of these hormones to the TSST by a linear 
mixed model with unstructured covariance structure. This was done to include all 
HPAA measures and not to lose information. Quadratic relationships were assessed by 
including a squared variable in the model and reactivity by including an interaction term 
with sampling time. In further analyses we used linear regression to demonstrate effect 
sizes of statistically significant associations with commonly used indicators of HPAA 
function during stress testing: baseline and post-stress peak concentrations, their relative 
increments (ratio of peak to baseline value), and time-weighted areas under the curve 
(AUC, calculated by the trapezoidal rule) as dependent variables. All analyses were 
adjusted for variables known to be associated with HPAA reactivity: sex, current age 
and BMI, time of day (dummy coded), and, except for analyses of sex differences, the 
use of oral estrogen therapy.  
In Study III, we used multiple linear regression analyses to test whether body size at 
birth, and 2, 7, and 11 years, and growth (gain in height and BMI) between these ages 
predicted CV reactivity to psychological stress in late adulthood. The growth variables 
we used were residuals from linear regression models of standardized body size during 
each timepoint versus the corresponding body size during the previous timepoint. The 
resulting scores are referred to as “conditional growth” (Osmond et al., 2007), which 
avoids the statistical artifact of regression to the mean and problems with high 
correlations between successive measurements. We also constructed conditional growth 
scores within the larger sample (n=2003), and tested whether the scores of our sample 
(n=144) differ from the whole cohort, but no differences were found (all P-values > 
0.2). 
All statistical analyses were performed using SPSS 12.0 (SPSS Inc., Chicago, 
Illinois). 
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 4  RESULTS 
4.1 CV and HPAA responses to stress (Studies I – IV) 
TSST induced robust CV responses to psychosocial stress. In both children and in 
adults, CV responses were mainly vascular, but in children there was also a clear 
cardiac sympathetic drive (measured with PEP) without an indication of significant 
stress-related changes in PNS (measured with HF HRV). In children, the average 
responses to TSST-C were 14.9 mmHg for SBP, 10 mmHg for DBP, 3.2 ms for PEP 
and 8.4 beats/second for HR. In adults, the average stress responses to TSST were 41.0 
mmHg for SBP, 21.9 mmHg for DBP and 16.1 beats / min for HR.  
In adults, there was also a robust response of saliva cortisol, serum cortisol and 
ACTH to psychosocial stress, which was indicated by significant main effects of time in 
mixed model analysis (all P -values < 0.0001). The average HPAA increment (the ratio 
of peak to baseline value) was 2.09 for salivary cortisol, 1.75 for plasma cortisol and 
2.32 for plasma ACTH.  
4.2 Markers of prenatal environment and CV stress reactivity in 
late adulthood (Study I) 
The most robust early determinant of BP reactivity in adults was gestational age; 
however, with opposite relationships between the sexes (P for interaction ≤ 0.001). A 
one-week decrease in gestational age was associated with a 3.1 mmHg (95% CI, 0.4 to 
5.9) and 1.2 mmHg (95% CI, -0.1 to 2.5) increase in systolic and diastolic BP reactivity 
in women, but with a 4.9 mmHg (95% CI, 1.9 to 8.0) and 2.3 mmHg (95% CI, 0.8 to 
3.7) decrease in systolic and diastolic BP reactivity in men. The relationships were 
linear and graded as depicted in Figure 6. The interaction term “gestational age x sex” 
was statistically significant in the analyses of BP reactivity.  
In women, smaller size at birth, including measures of length at birth, head 
circumference and PI failed to predict either BP or HR reactivity (all P-values>0.1, data 
not shown). In men, lower birth weight was significantly related to lower DBP 
reactivity (B=3.3; 95% CI, 0.1 to 6.6; P=0.04). However, this relationship disappeared 
after adjustment for gestational age (B=1.3; 95% CI, -2.0 to 4.7; P=0.4). No other 
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measure of size at birth was a significant predictor of CV reactivity in men. 
 
 
Figure 6. Association between unadjusted systolic BP and diastolic BP reactivity in response to 
experimentally induced psychological stress and gestational age at birth in both men and women at age 60 
to 70 years.  
 
4.3 Markers of prenatal environment and HPAA stress reactivity 
in late adulthood (Study II) 
It was then analysed whether the relationships between body size or gestational age at 
birth and the levels of cortisol and ACTH are different in men and women. Mixed-
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model analyses showed no statistically significant interactions between the effects of 
sex and any of these variables on levels of cortisol or ACTH (P values for interactions > 
0.2). The only statistically significant interaction on plasma cortisol responsiveness was 
found between the effects of sex and birth weight (P = 0.01) and sex and length at birth 
(P = 0.01). However, separate analyses in both sexes showed no statistically significant 
relationships between these measurements and plasma cortisol responsiveness (P values 
> 0.1).  
Stress-related HPAA activity in adults was associated with birth weight. A linear 
relationship between low birth weight and low plasma ACTH emerged but there was no 
linear relationship with cortisol. There were, however, quadratic relationships between 
birth weight and salivary (P = 0.001) and plasma cortisol (P = 0.005) but not with 
plasma ACTH (P = 0.1). The lowest peak salivary cortisol concentrations were seen in 
the lowest third of birth weights (adjusted for gestational age and sex): 12.9 nmol/litre 
(95% confidence interval of mean 11.2–15.0), compared with 17.1 nmol/litre (14.8 –
19.8) in the middle and 14.1 nmol/litre (12.6 –15.7) in the highest third of birth weights. 
Corresponding figures for plasma cortisol were 418 nmol/litre (380–459), 498 
nmol/litre (455–545), and 454 nmol/litre (428–482), and for plasma ACTH 8.17 
pmol/litre (6.98 –9.57), 12.42 pmol/litre (10.64 –14.51), and 11.50 pmol/litre (10.06 –
13.14), respectively. Results for areas under the curve were similar and no non-linear 
relationships were found for gestational age or ponderal index. 
These relationships are illustrated in Figure 7, which show salivary and plasma 
cortisol and plasma ACTH concentrations before and after the TSST according to thirds 
of birth weight adjusted for sex and gestational age (less than 3124 g; 3125–3496 g; 
more than 3497 g). 
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Figure 7. Salivary and plasma cortisol and plasma ACTH concentrations in groups according to thirds of 
birth weight adjusted for sex and gestational age. The concentrations are presented in geometric means, 
adjusted for sex, age, time of day, BMI, and the use of oral estrogen treatment. The bars represent 95% 
CIs. 
 
Plasma ACTH concentrations were associated with birth weight (approaching 
statistical significance; 1 kg higher birth weight corresponded to 12.1% higher ACTH; 
95% CI -1.5 to 27.5; P = 0.08) and length at birth (for each cm, 4.5% higher plasma 
ACTH; 95% CI 1.2– 8.0%; P = 0.008). These relationships were further illustrated by 
linear regression showing that a 1 kg higher birth weight was associated with 24.9% 
(95% CI 4.2–49.8%) higher peak ACTH and with 19.2% higher (95% CI 2.1–39.2%) 
ACTH AUC and that longer length at birth was also associated with higher baseline (P 
= 0.02) and peak (P = 0.002) ACTH and ACTH AUC (P = 0.002). No associations were 
seen with ponderal index (mixed model P > 0.7) or gestational age (P > 0.6) at birth, 
and birth data were not related to ACTH stress response (P > 0.2). 
4.4 Markers of childhood growth and CV stress reactivity in late 
adulthood (Study III) 
Before investigating the relationships to childhood growth, we investigated 
relationships to absolute measures of height and BMI. Height at 2, 7 or 11 years or in 
adulthood did not predict BP or HR reactivity in late adulthood (all P-values > 0.1). 
Figure 8 shows the relationship between BMI at different ages in childhood and adult 
BP reactivity. This association became stronger with increasing age, reaching statistical 
significance with SBP reactivity at approximately 9 years. 
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Figure 8. Standardized regression coefficients (solid lines) and 95% confidence limits (dashed lines) for 
both systolic and diastolic BP reactivity adjusted with current age and sex, according to annual body mass 
index (BMI) from birth to 11 years and at the time of the Trier Social Stress Test. Ages from 3 to 5 are 
not included, due to infrequent measurements within the children during this period. Standardized 
regression coefficients (y-axis) are interpreted as the standard deviation (SD) change of BP reactivity for
one SD change in BMI at each age.
We then found that several of the actual childhood growth scores were related to BP 
reactivity to psychosocial stress in late adulthood. In both women and men, gain in body 
mass index (BMI; kg/m2) between 7-11 years was related to BP reactivity to TSST. For 
each 1-SD more rapid gain in BMI from 7 to 11 years, SBP reactivity increased by 3.8 
mmHg and DBP reactivity by 1.4 mmHg.   
By contrast, effects of height gain were dissimilar between sexes (Figure 9). In men, 
one SDS increase in conditional infant (0-2 years) height gain was associated with a 2.4 
mmHg (95 % CI, 0.3 to 4.4; P = 0.02) increase, but in women with a 2.9 mmHg (95 % 
CI, 0.4 to 5.3, P = 0.02) decrease in DBP reactivity. In addition, slower height gain 
during 2-7 years was associated with higher SBP reactivity only in men, so that one 
SDS increase in height gain during 2-7 years in men was associated with a decrease of 
6.9 mmHg (95% CI, 1.2 to 12.7; P = 0.02) in SBP reactivity. Adjusting for adult body 
size, body size at birth, or childhood socio-economic status did not change the results.  
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Figure 9. Opposite relationships in men and women in the association between diastolic reactivity to 
psychological stress and standard deviation increase in conditional height gain during years 0-2. 
 
4.5 Prenatal growth markers and CV stress reactivity and 
recovery in childhood (Study IV) 
We first investigated associations to baseline CV scores. Among girls, a one SD lower 
birth length SD score was related to 2.7 mmHg (95% CI, 0.7 to 4.6; P=0.008) lower 
baseline SBP and 2.2 mmHg (95% CI, 0.7 to 3.6; P=0.004) lower baseline DBP, 
whereas there was no association between ponderal index and baseline BP (P-
values>0.7). Among boys, no significant associations between birth length SD score 
and baseline SBP/DBP were found (both P-values>0.4), while a one kg/ cm3 lower 
ponderal index was associated with a 1.0 mmHg higher (95% CI, 0.0 to 1.9; P=0.05) 
baseline SBP. P-values for interaction ‘birth length SD*sex’ was 0.04 for baseline SBP, 
0.03 for baseline DBP, and for interaction ‘ponderal index*sex’ it was 0.2 for baseline 
SBP.  
Next, we examined associations to BP reactivity. Among girls, a one SD lower 
length at birth was related to increases of 1.7 mmHg (95% CI, 0.1 to 3.3; P=0.04) and 
1.0 mmHg (95% CI, -0.1 to 2.2; P=0.06) in SBP and DBP reactivity, respectively, while 
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ponderal index at birth was not associated with BP reactivity (P-values>0.5). Among 
girls, a one SD lower length at birth was related to increases of 1.7 mmHg (95% CI, 0.1 
to 3.3; P=0.04) and 1.0 mmHg (95% CI, -0.1 to 2.2; P=0.06) in SBP and DBP 
reactivity, respectively, while ponderal index at birth was not associated with BP 
reactivity (P-values>0.5). Among boys, no significant associations between birth length 
SD score and SBP/DBP reactivity were found (P-values>0.8), whereas a one kg/cm3 
lower reading in the ponderal index was associated with a 1.1 mmHg lower SBP 
reactivity (95% CI, 0.4 to 1.8; P=0.002) and 0.7 mmHg lower DBP reactivity (95% CI 
0.2 to 1.1; P=0.008) reactivity, respectively. Relationships between BP reactivity and 
birth weight SD score were linear and graded as depicted in Figure 10. 
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Figure 10. Relationships of birth weight SD score to systolic and diastolic BP reactivity to psychosocial 
stress in both girls and boys aged 8. BP responses are adjusted with age, current height/BMI, maternal 
tobacco/alcohol/liquorice use and socioeconomic status. 
 
After this, we examined associations with BP recovery scores. Among girls, a one 
SD lower length at birth SD score was related to a 1.3 mmHg (95% CI, 0.3 to 2.4; 
P=0.01) lower DBP recovery score, while ponderal index in girls had no significant 
effects (P-values>0.6 for SBP/DBP recovery). Again, among boys there were no effects 
for length at birth (P-values>0.1), whereas a one kg/cm3 lower ponderal index was 
associated with a 0.8 mmHg (95% CI, 0.2 to 1.4; P=0.01) and 0.5 mmHg (95% CI, 0.0 
to 0.9; P=0.05) lower SBP and DBP recovery score, respectively. (P-values for 
interactions ‘birth length SD*sex’ and ‘ponderal index*sex’<0.05). 
Birth weight SD score was associated with none of the CO values among either girls 
or boys. Neither was it associated with TPR among girls, while among boys, a one SD 
lower birth weight was related to an 87.7 dynes*sec*cm-5 (95% CI, 3.2 to 172.2; 
P=0.04) higher baseline TPR and 4.1 % (95% CI, 0 to 8.1; P=0.03) lower TPR 
reactivity to stress (P-value for interaction ‘birth weight SD*sex’=0.06 for both baseline 
TPR and TPR reactivity). The baseline TPR result in boys became statistically 
significant only after controlling for current height or BMI, while the association with 
TPR reactivity was not affected by current body size. The result on reactivity remained 
similar also when further controlling for the baseline TPR value. Among boys, a one 
kg/cm3 lower ponderal index was associated with 2.0 % (95% CI, 0.0 to 3.9; P=0.03) 
lower TPR reactivity (P>0.9 in girls) (P-value for interaction ’ponderal 
index*sex’=0.003). 
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5  DISCUSSION 
 
The present study investigated in children and in adults whether physiological stress 
reactivity is associated with markers of growth of prenatal or postnatal period until 11 
years of age. The main results confirmed several of our hypotheses. We found that size 
at birth was associated with late adulthood HPAA activity during psychosocial stress, 
and gain in BMI during years 7-11 was associated with CV stress responses in late 
adulthood. We also found that size at birth in children and gestational age and early 
postnatal (0-2 years and 2-7 years) gains in height in adults were associated with CV 
stress responses. These results were, however, sex-specific. Given that heightened CV 
stress responses and increased HPAA activity are markers of CV disease vulnerability, 
our results may partly explain the associations between early growth and later CV 
disease. 
The value of this thesis is dependent upon several aspects. First, we applied a wide 
variety of different physiological markers to describe cardiac, vascular and endocrine 
reactions to stress. Second, our stress test is well validated and offers the most robust 
and reliable CV and HPAA responses. Third, we applied TSST to both children and late 
middle aged adults, age groups which are rarely used in this field. Fourth, we were able 
to link not only prenatal but also postnatal markers of growth to CV stress responses in 
late adulthood. These aspects enable a more comprehensive perspective on the health 
effects of the early environment.  
Previous studies in this field have nevertheless shown some discrepant results and 
our studies are no exceptions. Sex- and age -specificity of the associations between 
early growth and later physiological stress reactivity still remain largely unexplained 
and warrant further investigation into underlying mechanisms. In addition, birth weight 
and gestational age are only proxies to prenatal environment and we are unaware what 
are the exact factors and critical windows in the course of fetal development that may 
have long-lasting effects on human health late into adulthood.  
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5.1 Markers of prenatal growth and CV reactivity to stress in 
childhood and in late adulthood 
Similar to others (Jones et al., 2008; Ward et al., 2004), we found profound sex 
differences in prenatal and early postnatal programming of CV responses to stress in 
childhood and in adulthood. It is well documented that there are great sex differences in 
BP dynamics and its control mechanisms (Convertino, 1998; K. A. Matthews, Woodall, 
& Stoney, 1990; Shoemaker, Hogeman, Khan, Kimmerly, & Sinoway, 2001). 
Interestingly, animal studies have shown that estrogen and testosterone have opposing 
effects on postnatal BP only when there has been nutritional deprivation during the fetal 
period (Ojeda et al., 2007; Ojeda, Grigore, Robertson, & Alexander, 2007). Due to these 
sex differences in studies of prenatal CV programming, we will discuss the results of 
Studies I and IV separately in men and women.  
5.1.1 Females  
We found in 7-9 year old girls who were born light or short that BP was low during the 
baseline prior stress test but showed a strong increase and stayed high during recovery 
period 20 minutes after the stress had ended. Previous studies in adult women concur 
with these findings of small size at birth and heightened BP reactivity to stress (Painter 
et al., 2006; Ward et al., 2004). In addition, low birth weight girls in our study were 
under high cardiac sympathetic activity at the time of stress, which is consistent with the 
rapid rise of BP.  
In women aged 60-70, it was not low birth weight but low gestational age that was 
associated with higher BP and HR reactivity to psychosocial stress. It may be that the 
effects of birth weight are age-dependent; a study in younger individuals born full-term 
and a study in younger individuals born with a very low-birth weight did not find the 
association with gestational age (Pyhala et al., 2009; Ward et al., 2004). It has been 
demonstrated that BP dynamics are altered with increasing age (Barnett et al., 1999; 
Reckelhoff, 2001; Uchino et al., 1999) and it might be that the early life events for 
which gestational age serves as a marker, appear later in adulthood. Our findings may 
therefore indicate an alternative pathway from low gestational age to CV disease 
through heightened CV activity. This is plausible given that both low gestational age 
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and heightened CV activity are associated with adverse CV health outcomes later in life. 
In addition, gestational age might be linked with maternal plasma CRH levels (McLean 
et al., 1995), which moderate the sympathetic innervation and cardiac noradrenergic and 
sympathetic processes with effects lasting until adulthood. 
Generally, our results in females add to previous literature that women with a low 
birth weight or short length at birth might develop high BP and CV diseases due to 
heightened BP reactivity to stress and heightened cardiac sympathetic activity and due 
to the inability of BP to quickly stabilize back to baseline after stress has ended. Then 
again, if born early, there may be a risk of heightened CV activity and on account of 
that a risk of CV disease later in adulthood (Koupil, Leon, & Lithell et al., 2005; 
Osmond et al., 2007).  
5.1.2 Males 
In contrast to girls, low birth weight boys aged 7-9 had a high baseline BP prior stress 
test and generally low cardiac sympathetic activity, but only after adjusting with current 
body size. It was shown that the highest baseline BP was seen in boys who had a low 
birth weight but rapidly put on weight during childhood. Similar to our findings, 
Mirzeai et al. (Mirzaei, Taylor, Morrell, & Leeder, 2007) noticed that in boys, but not in 
girls, the negative association between birth weight and BP is significant only after 
adjusting with current body size. Independent of current size, we found that boys had a 
low TPR reactivity to stress and a rapid recovery of both BP and cardiac sympathetic 
activity 20 minutes after stress had ended. This may protect the individual from 
developing CV disease.  
There were no significant associations between size at birth and PNS activity, 
reactivity or recovery in boys. However, speech tasks involve irregular breathing 
patterns, which may complicate the interpretation of HRV indices (Beda, Jandre, 
Phillips, Giannella-Neto, & Simpson, 2007). Breathing should therefore be controlled in 
future investigations. 
We found that low birth weight boys exhibiting higher baseline BP together with 
lower BP stress reactivity might be the results of their generally low cardiac 
sympathetic activity we found. Jones et al. (Jones et al., 2008) also witnessed a negative 
association between birth weight and baseline CV activity in 7-9 year old boys when 
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current BMI was adjusted. It may be that cardiac sympathetic activity works as a buffer 
for changes in BP. 
In contrast to our results with 7-9 year old boys, we found in men aged 60-70 that it 
was again not size at birth but gestational age which was positively associated with CV 
reactivity to stress. There is no ready explanation for this, but similar to the results for 
women, it may be that the early life events for which gestational age serves as a marker 
appear later in adulthood and that the phenomenon is highly age-dependent. While an 
inverse association between gestational age and resting BP in men has been described in 
young military conscripts (Johansson et al., 2005; Leon et al., 2000) the sparse data 
available about middle-aged men have shown discrepant results (Martyn et al., 1995; 
Mi et al., 2000; Siewert-Delle & Ljungman, 1998).  
These results add to the complex nature of prenatal programming of CV stress 
activity in males. However, the strong sex differences regarding peripheral resistance in 
the older study sample in Study I might also be explained by hormonal interference. 
Testosterone is suggested to upregulate neuropeptide Y(Zukowska-Grojec, 1995), 
which is a potent vasoconstrictor, and testosterone has been shown to enhance the 
contractile effects of endothelin-1 in porcine coronary artery rings, an effect which is 
attenuated by estrogen (Teoh, Quan, Leung, & Man, 2000). However, the differences in 
sex hormones are probably somewhat small and the peripheral interference of these 
hormones are unlikely to fully explain the sex differences. Such an effect would, 
however, be of significant potential clinical relevance as it is suggested that especially 
among hypertensive patients the BP responses to stress are driven peripherally rather 
than centrally (Dimsdale, Ziegler, Mills, Delehanty, & Berry, 1990), and among the 
elderly hypertension is characterized by increased vascular resistance and reduced 
cardiac output (Sowers & Lester, 2000). This underlying cause to sex-specific 
programming remains however speculative. 
5.2 Markers of prenatal growth and late adulthood HPAA 
reactivity to stress 
We found in individuals in their late adulthood that size at birth was associated with 
HPAA activity during baseline, stress and recovery such that the highest overall cortisol 
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and ACTH concentrations were seen in individuals whose birth weight was in the 
middle third and lowest concentrations in individuals with low birth weight. 
Although apparently counterintuitive, low birth weight has previously been 
associated with low HPAA activity in late adulthood. Ward et al. (Ward, Syddall, 
Wood, Chrousos, & Phillips, 2004) compared bottom and top birth weight quartiles and 
noticed that there were lower ACTH and cortisol responses to a dexamethasone 
(synthetic glucocorticoid) test in the low birth weight group. Studies with psychosocial 
stressors have found a negative association between birth weight and HPAA activity in 
male twins (Wust et al., 2005) and in 7-9 –year-old boys (Jones et al., 2006).  
Unlike in our studies of CV activity (studies I, III & IV), we did not find any 
significant sex effects on our HPAA study. This is similar to what has previously been 
suggested (Reynolds et al., 2005). Additionally, it was birth weight that predicted 
HPAA responses and gestational age that predicted CV activity. It has to be noted that 
although producing a unified stress response, the connections between CV and HPAA 
are complicated. For example, glucocorticoids inhibit sympathetic nervous system 
activity (Lenders, Golczynska, & Goldstein, 1995), increase the sensitivity of the 
myocardium to -adrenergic stimulation (Szemeredi, Bagdy, Kopin, & Goldstein, 1989) 
and effect the baroreflex control of heart rate (Scheuer & Bechtold, 2002), but in certain 
situations glucocorticoids activate SNS and decrease beta-adrenergic stimulation (Seckl 
& Meaney, 2004). Therefore, it might be that programming of both CV and HPAA 
stress responses have their own separate and unique pathways. 
5.3 Markers of childhood growth and late adulthood CV 
reactivity to stress
In Study III, we found that childhood growth trajectory predicts BP and HR reactivity to 
psychological stress in late adulthood. A rapid gain in BMI between 7 and 11 years of 
age predicted heightened BP reactivity, which is in line with previous findings 
concerning disease outcomes. It has also shown that growth during infancy has a 
modest association (Law et al., 2002), whereas increase in BMI later in childhood has a 
stronger association with the resting level of BP later in adulthood (Cole, 2004; Falkner, 
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Hulman, & Kushner, 1998; Hardy, Wadsworth, Langenberg, & Kuh, 2004). 
Epidemiological studies in the Helsinki Birth Cohort have revealed distinct childhood 
growth patterns associated with adult diagnosis of CHD (J. G. Eriksson et al., 1999) and 
type 2 diabetes (J. G. Eriksson et al., 2006), and a strong predictor in both of these 
studies is rapid gain in BMI before 11 years of age. This was also found for people aged 
60-70 with a diagnosis of hypertension (J. G. Eriksson et al., 2007). In this study, the 
risk of hypertension depended on the rate of growth rather than the body size attained at 
any particular age. Interestingly, this was true only for people with a more severe 
hypertension. People with no previous diagnosis of hypertension but who had a systolic 
blood pressure of >=140 mmHg or a diastolic blood pressure of >=90 mmHg on a visit 
to clinic during the study had a persisting small body size until 11 years of age. Our 
results resemble more with the growth profile for people with a more severe 
hypertension and also reinforce the suggestions that, besides actual size, the rate of 
growth during childhood may have independent health effects.  
While people who gain BMI rapidly in childhood are more likely to be obese in adult 
life, our results were not explained by BMI in adulthood. Changes in body composition 
are however one possibility. BMI gain during late childhood reflects increase in body 
fat content and central adiposity rather than increase in lean body mass (Sachdev et al., 
2005; Yliharsila et al., 2007). The latter is associated with increased BP response to 
stress (Barnes, Treiber, Davis, Kelley, & Strong, 1998; Goldbacher, Matthews, & 
Salomon, 2005), and obesity is characterized by increased sympathetic activity and 
overall autonomic imbalance (Riva et al., 2001). However, further studies are needed in 
order to clarify whether changes in body composition during childhood growth have 
long-term effects to CV reactivity. 
We also found that the effects of early postnatal height gain were dissimilar between 
the sexes. Evidence from the Whitehall II studies suggest that shorter leg length in 
adulthood, a proxy for slow growth in height and low socioeconomic status during 
childhood before puberty, is associated with a gradual rise in BP with age and several 
other CHD risk factors (Ferrie, Langenberg, Shipley, & Marmot, 2006; Langenberg, 
Hardy, Breeze, Kuh, & Wadsworth, 2005). Specific evidence for the role of slow 
growth in height and adult disease came from a Helsinki Birth Cohort Study showing 
that high BP in people with no previous diagnosis of hypertension is predicted by slow 
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growth in height during the first years of life (J. G. Eriksson et al., 2007). Our results 
with slow height gain between birth and 2 years in women and slow height gain 
between 2 and 7 in men leading to heightened BP reactivity to psychosocial stress in 
adult age concur with these findings.  
5.4 Methodological considerations 
A recent study suggested that to achieve the highest laboratory to life generalizability 
different types of public speaking tasks should be used, the responses of which are then 
aggregated (Kamarck, Debski, & Manuck, 2000). Although a highly ecologically valid 
experiment among stress tests, the generalizability of TSST to real life environment is 
moderate at best. There are numerous ways to measure stress in the laboratory 
environment, and there is constant debate whether such measurements are ecologically 
valid. There are multiple mental and physical challenges in our daily lives, and each of 
them has their own unique spectrum of physiological responses. TSST produces high 
responses of cortisol, moderately high sympathetic response and a high BP response 
that is more vascular than cardiac. Other stress tests and real life measurements with 
ambulatory devices are needed to both confirm and expand these findings. We also 
measured only parts of HPAA, CV system and ANS activity. It would therefore be 
interesting to measure more comprehensively both systems, their interactions to one 
another, or even the responses of other systems to psychosocial stress such as immune 
and central nervous system. 
Additionally, size at birth is only a summary measure of prenatal adaptations. Babies 
born small may have achieved their genetic growth potential and are in the lower tail of 
the birth weight distribution, whereas other babies with similar weight at birth may have 
experienced a prenatal nutritional deficit, which has slowed their growth, and later on 
experience catch-up growth to gain their genetic growth potential. Therefore, further 
studies with improved surveillance and markers of prenatal environment are needed. 
Finally, since prenatal stress may also contribute to our findings, future studies should 
investigate with sophisticated statistical models what exactly underlies with the 
associations between prenatal growth and later stress reactivity to psychosocial stress. 
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5.5 Conclusions 
In summary, these studies provide support for the hypothesis that CV reactivity to and 
recovery from stress may be determined in utero and during the early postnatal period. 
We suggest that in similar studies both the gender of the subjects and the peripheral and 
central components should be investigated separately. Second, it may also be that both 
hyper- and hypocortisolism is programmed during the fetal period. Third, our result 
highlights the role of gestational age at birth as a potential marker of intrauterine 
conditions in birth cohort studies. 
Overall, these results reinforce previous suggestions that intrauterine programming 
of BP, sympathetic, and HPAA activity may be important contributors to the link 
between fetal and early growth and adult CV disease. 
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